Abstract:Oral Chinese patent medicine is the essence of effective prescriptions created and summarized by Chinese medical scientists through thousands of years of medical practice. It is portable and convenient, with an obvious curative effect and other characteristics. However, at present, oral Chinese patent medicine is rich in dosage forms, various in types, complex in mechanism of action, and broad in clinical positioning. In clinical application, there are often cases of drug use without reference to instructions,repeated drug use, and prolonged drug use, which highlights safety problems such as adverse reactions and hepatorenal toxicity. Oral Chinese patent medicine pharmacovigilance is facing challenges. World Health Organization(WHO) has issued the WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems, and International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use(ICH) has issued the ICH E2 pharmacovigilance guidelines. The United States has issued the Pharmacovigilance management standards and pharmacoepidemiological assessment guidelines, and the European Union has issued the Guidelines on good pharmacovigilance practices. Japan, South Korea, and other countries in the Asia Pacific region have established their own pharmacovigilance systems, but currently, there are no pharmacovigilance guidelines related to oral Chinese patent medicine in China. Therefore, experts from many disciplines and fields in China were invited to jointly develop the Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines, which aims to develop pharmacovigilance guidelines for clinical application that are consistent with China's national conditions and highlight the characteristics of oral Chinese patent medicine, and provide guidance for clinically safe and rational drug application in medical institutions.

Current Status, Problems and Countermeasures for General Hospitals in Introducing Chinese Patent Medicine

Innovative Pharmaceutical Service Practice of Medical Institutes in Zhejiang Area

Recent advances in Chinese patent medicines entering the international market

Analysis of Related Literatures of New Drug Introduction Management in Medical Institutions in China

Analysis of Use of Chinese Traditional Patent Drugs in a 3A Grade Hospital during 2005—2007

Notice for Western Medicine Physicians in Clinical Use of Chinese Patent Drugs

Take the Current Situation of Patent in Peking University Third Hospital As a Case to Study

A Development Opportunity and Strategic Thinking for the Comprehensive Healthcare Industry of Traditional Chinese Medicine

Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions

Current situation and countermeasures of patent transformation in university affiliated hospital

Progress of Modernization in Chinese Traditional Medicine and Patent Medicine

Analysis of Outpatient Chinese Traditional Patent Medicine Prescriptions During the Third Quarter of 2008 in Our Hospital

Analysis of Medicine-related Issues in New "patent Law"

Literature Analysis on Drug introducing Management in Foreign hospitals

[Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines]

Technical specifications for hospital-based intensive monitoring of post-marketing Chinese patent medicine

Utilization of Chinese Patent Medicines in Our Hospital

Analysis on patents of health care products with substances of medicine food homology in China

[Traditional Chinese medicine preparations in medical institutions: current situation and inspirations on research and development of new traditional Chinese medicine preparations]

Analysis on the Promotion of Patent Conversion Strategy of Traditional Chinese Medicine

Investigation and Analysis of the Application and Management of Medicines Brought into Hospital by Patients